QurAlis

Cambridge, United States

QurAlis is a biotechnology company that creates precision medicine solutions to cure ALS and FTD.

Mar 2023

Series B

Top Investors

Sanofi VenturesPolaris PartnersDementia Discovery FundEQT Life SciencesAlexandria Venture Investments

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are QurAlis's investors?

QurAlis's investors include Sanofi Ventures, Polaris Partners, Dementia Discovery Fund, EQT Life Sciences, Alexandria Venture Investments.

Where is QurAlis headquartered?

QurAlis is headquartered in Cambridge, United States.

What does QurAlis do?

QurAlis is a biotechnology company that creates precision medicine solutions to cure ALS and FTD.

What stage is QurAlis at?

QurAlis is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 9, 2023.

MLA

"QurAlis — Funding & Investors." VCBacked, March 9, 2023, https://www.vcbacked.co/company/quralis. Accessed July 1, 2026.

APA

VCBacked. (2023). QurAlis — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/quralis

Wikipedia (cite web)

{{cite web |title=QurAlis — Funding & Investors |url=https://www.vcbacked.co/company/quralis |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 9, 2023.